The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
but there are data that we've looked at that suggest a monotonic Improvement in all cause mortality as average blood glucose goes down measured by hemoglobin A1c in the non-diabetic range meaning people with an A1C of five live longer than people with an A1C of 5.5 live longer than people with an A1C of six all of whom are D non-diabetic
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
We have the literature that says the lower the A1C, the lower the all-C cause mortality, it's a monotonic reduction that knows no lower limit.